Spotlight
Video

Crizotinib for First Line Treatment of ALK or ROS1 Rearrangements [720p]

cancergrace has 1140 videos Subscribe Here

Loading........
Description: Dr. Ross Camidge, University of Colorado, explains the preference for crizotinib rather than platinum doublet chemotherapy as first line treatment for patients with ALK or ROS1 rearrangements.
Shared By : cancergrace
Posted on : 05/17/18
Added : 1 year ago
Category : General